CA2706481C - Oral care regimen - Google Patents
Oral care regimen Download PDFInfo
- Publication number
- CA2706481C CA2706481C CA2706481A CA2706481A CA2706481C CA 2706481 C CA2706481 C CA 2706481C CA 2706481 A CA2706481 A CA 2706481A CA 2706481 A CA2706481 A CA 2706481A CA 2706481 C CA2706481 C CA 2706481C
- Authority
- CA
- Canada
- Prior art keywords
- oral care
- oral
- composition
- agent
- abrasive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 claims abstract description 154
- 230000000737 periodic effect Effects 0.000 claims abstract description 68
- 238000012423 maintenance Methods 0.000 claims abstract description 36
- 150000003839 salts Chemical group 0.000 claims abstract description 20
- 150000001413 amino acids Chemical class 0.000 claims abstract description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 31
- -1 triclosan monophosphate Chemical class 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 16
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 claims description 12
- 238000011282 treatment Methods 0.000 claims description 11
- 229960003500 triclosan Drugs 0.000 claims description 11
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 10
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 9
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 9
- YFVBASFBIJFBAI-UHFFFAOYSA-M 1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=CC=C1 YFVBASFBIJFBAI-UHFFFAOYSA-M 0.000 claims description 8
- 239000003242 anti bacterial agent Substances 0.000 claims description 8
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 8
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- RYJDNPSQBGFFSF-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;carbonic acid Chemical compound OC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N RYJDNPSQBGFFSF-WCCKRBBISA-N 0.000 claims description 6
- 239000004475 Arginine Substances 0.000 claims description 6
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 claims description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 6
- 239000004075 cariostatic agent Substances 0.000 claims description 6
- 239000003086 colorant Substances 0.000 claims description 6
- QSFOWAYMMZCQNF-UHFFFAOYSA-N delmopinol Chemical compound CCCC(CCC)CCCC1COCCN1CCO QSFOWAYMMZCQNF-UHFFFAOYSA-N 0.000 claims description 6
- 229960003854 delmopinol Drugs 0.000 claims description 6
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 claims description 6
- 229960001774 octenidine Drugs 0.000 claims description 6
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 claims description 6
- 229940084560 sanguinarine Drugs 0.000 claims description 6
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 claims description 6
- RWMSXNCJNSILON-UHFFFAOYSA-N 2-[4-(2-propylpentyl)piperidin-1-yl]ethanol Chemical compound CCCC(CCC)CC1CCN(CCO)CC1 RWMSXNCJNSILON-UHFFFAOYSA-N 0.000 claims description 5
- OJIYIVCMRYCWSE-UHFFFAOYSA-M Domiphen bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1 OJIYIVCMRYCWSE-UHFFFAOYSA-M 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 241000229143 Hippophae Species 0.000 claims description 5
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 5
- 241000218378 Magnolia Species 0.000 claims description 5
- 241000241413 Propolis Species 0.000 claims description 5
- 229950010221 alexidine Drugs 0.000 claims description 5
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 claims description 5
- 229960001859 domiphen bromide Drugs 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229910021645 metal ion Inorganic materials 0.000 claims description 5
- 229950002404 octapinol Drugs 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 229940069949 propolis Drugs 0.000 claims description 5
- 239000000341 volatile oil Substances 0.000 claims description 5
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 claims description 4
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 claims description 4
- 108010062877 Bacteriocins Proteins 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 4
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 4
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 4
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 claims description 4
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 claims description 4
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 claims description 4
- 108010053775 Nisin Proteins 0.000 claims description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 4
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 4
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 4
- 229940045110 chitosan Drugs 0.000 claims description 4
- 229960003260 chlorhexidine Drugs 0.000 claims description 4
- 229910001431 copper ion Inorganic materials 0.000 claims description 4
- 229960003624 creatine Drugs 0.000 claims description 4
- 239000006046 creatine Substances 0.000 claims description 4
- 239000003975 dentin desensitizing agent Substances 0.000 claims description 4
- 229930003935 flavonoid Natural products 0.000 claims description 4
- 150000002215 flavonoids Chemical class 0.000 claims description 4
- 235000017173 flavonoids Nutrition 0.000 claims description 4
- 150000002241 furanones Chemical class 0.000 claims description 4
- 229960004867 hexetidine Drugs 0.000 claims description 4
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 claims description 4
- VVOAZFWZEDHOOU-UHFFFAOYSA-N honokiol Natural products OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 claims description 4
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims description 4
- 235000007708 morin Nutrition 0.000 claims description 4
- 239000004309 nisin Substances 0.000 claims description 4
- 235000010297 nisin Nutrition 0.000 claims description 4
- 150000002978 peroxides Chemical class 0.000 claims description 4
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 claims description 4
- 229950000975 salicylanilide Drugs 0.000 claims description 4
- IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 claims description 4
- 229940096998 ursolic acid Drugs 0.000 claims description 4
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 claims description 4
- 241000209507 Camellia Species 0.000 claims description 3
- 239000004398 Ethyl lauroyl arginate Substances 0.000 claims description 3
- 235000018597 common camellia Nutrition 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- XJTMYVOVQZMMKX-KRWDZBQOSA-N ethyl (2s)-5-(diaminomethylideneamino)-2-(dodecanoylamino)pentanoate Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(=O)OCC)CCCN=C(N)N XJTMYVOVQZMMKX-KRWDZBQOSA-N 0.000 claims description 3
- 235000019455 ethyl lauroyl arginate Nutrition 0.000 claims description 3
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical compound C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 claims description 3
- 229940024606 amino acid Drugs 0.000 claims 6
- ANAAMBRRWOGKGU-UHFFFAOYSA-M 4-ethyl-1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=C(CC)C=C1 ANAAMBRRWOGKGU-UHFFFAOYSA-M 0.000 claims 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 2
- 229960003121 arginine Drugs 0.000 claims 2
- 229960003589 arginine hydrochloride Drugs 0.000 claims 2
- CCTIOCVIZPCTGO-BYPYZUCNSA-N phosphoarginine Chemical compound OC(=O)[C@@H](N)CCCNC(=N)NP(O)(O)=O CCTIOCVIZPCTGO-BYPYZUCNSA-N 0.000 claims 2
- MHVJRKBZMUDEEV-APQLOABGSA-N (+)-Pimaric acid Chemical compound [C@H]1([C@](CCC2)(C)C(O)=O)[C@@]2(C)[C@H]2CC[C@](C=C)(C)C=C2CC1 MHVJRKBZMUDEEV-APQLOABGSA-N 0.000 claims 1
- 238000004140 cleaning Methods 0.000 abstract description 31
- 238000000034 method Methods 0.000 abstract description 21
- 230000036541 health Effects 0.000 abstract description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 88
- 239000000377 silicon dioxide Substances 0.000 description 40
- 239000002245 particle Substances 0.000 description 36
- 239000003082 abrasive agent Substances 0.000 description 30
- 238000010521 absorption reaction Methods 0.000 description 18
- 239000003921 oil Substances 0.000 description 18
- 230000002272 anti-calculus Effects 0.000 description 11
- 210000000214 mouth Anatomy 0.000 description 10
- 229940091249 fluoride supplement Drugs 0.000 description 9
- 239000000499 gel Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229910052618 mica group Inorganic materials 0.000 description 7
- 230000009885 systemic effect Effects 0.000 description 7
- 239000000017 hydrogel Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000010445 mica Substances 0.000 description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 6
- 239000000606 toothpaste Substances 0.000 description 6
- 239000000551 dentifrice Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229940034610 toothpaste Drugs 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 4
- 208000002925 dental caries Diseases 0.000 description 4
- 229960001245 olaflur Drugs 0.000 description 4
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 229920000388 Polyphosphate Polymers 0.000 description 3
- 238000005299 abrasion Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229940043256 calcium pyrophosphate Drugs 0.000 description 3
- 230000036996 cardiovascular health Effects 0.000 description 3
- 239000008119 colloidal silica Substances 0.000 description 3
- 210000004268 dentin Anatomy 0.000 description 3
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 3
- 238000011086 high cleaning Methods 0.000 description 3
- 230000009610 hypersensitivity Effects 0.000 description 3
- 238000005498 polishing Methods 0.000 description 3
- 239000001205 polyphosphate Substances 0.000 description 3
- 235000011176 polyphosphates Nutrition 0.000 description 3
- 239000011775 sodium fluoride Substances 0.000 description 3
- 235000013024 sodium fluoride Nutrition 0.000 description 3
- 229960000414 sodium fluoride Drugs 0.000 description 3
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 3
- 235000019731 tricalcium phosphate Nutrition 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 2
- 229960002799 stannous fluoride Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 2
- 239000002966 varnish Substances 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 239000011746 zinc citrate Substances 0.000 description 2
- 235000006076 zinc citrate Nutrition 0.000 description 2
- 229940068475 zinc citrate Drugs 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- UOWIFEANNONTKY-UHFFFAOYSA-N 2-hydroxy-5-octanoyl-n-[3-(trifluoromethyl)phenyl]benzamide Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(=O)NC=2C=C(C=CC=2)C(F)(F)F)=C1 UOWIFEANNONTKY-UHFFFAOYSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- 239000004261 Ascorbyl stearate Substances 0.000 description 1
- 241001132374 Asta Species 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 229910052580 B4C Inorganic materials 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- QCZAWDGAVJMPTA-RNFRBKRXSA-N ClC1=CC=CC(=N1)C1=NC(=NC(=N1)N[C@@H](C(F)(F)F)C)N[C@@H](C(F)(F)F)C Chemical compound ClC1=CC=CC(=N1)C1=NC(=NC(=N1)N[C@@H](C(F)(F)F)C)N[C@@H](C(F)(F)F)C QCZAWDGAVJMPTA-RNFRBKRXSA-N 0.000 description 1
- 229910021593 Copper(I) fluoride Inorganic materials 0.000 description 1
- 229910021594 Copper(II) fluoride Inorganic materials 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 241000490025 Schefflera digitata Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 108091008874 T cell receptors Proteins 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- HFIGWKOFZLNOQK-UHFFFAOYSA-K [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] Chemical class [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] HFIGWKOFZLNOQK-UHFFFAOYSA-K 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- LDDQLRUQCUTJBB-UHFFFAOYSA-N ammonium fluoride Chemical class [NH4+].[F-] LDDQLRUQCUTJBB-UHFFFAOYSA-N 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 235000019276 ascorbyl stearate Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- INAHAJYZKVIDIZ-UHFFFAOYSA-N boron carbide Chemical compound B12B3B4C32B41 INAHAJYZKVIDIZ-UHFFFAOYSA-N 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 229940095626 calcium fluoride Drugs 0.000 description 1
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical class OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000805 composite resin Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- GWFAVIIMQDUCRA-UHFFFAOYSA-L copper(ii) fluoride Chemical compound [F-].[F-].[Cu+2] GWFAVIIMQDUCRA-UHFFFAOYSA-L 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- DGTVXEHQMSJRPE-UHFFFAOYSA-N difluorophosphinic acid Chemical compound OP(F)(F)=O DGTVXEHQMSJRPE-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 229960000878 docusate sodium Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000015250 liver sausages Nutrition 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 229940096978 oral tablet Drugs 0.000 description 1
- MMCOUVMKNAHQOY-UHFFFAOYSA-L oxido carbonate Chemical compound [O-]OC([O-])=O MMCOUVMKNAHQOY-UHFFFAOYSA-L 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 230000001706 oxygenating effect Effects 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 229910052628 phlogopite Inorganic materials 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000007406 plaque accumulation Effects 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000006254 rheological additive Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052604 silicate mineral Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- WBGSMIRITKHZNA-UHFFFAOYSA-M trisodium;dioxido(oxidooxy)borane Chemical compound [Na+].[Na+].[Na+].[O-]OB([O-])[O-] WBGSMIRITKHZNA-UHFFFAOYSA-M 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention includes methods of cleaning an oral surface, maintaining oral health and/or increasing oral health.
Such methods encompass contacting an oral surface with a primary oral care composition at least once daily, contacting the oral surface with a periodic oral care maintenance composition at least once monthly, wherein the periodic oral care maintenance com-position comprises a basic amino acid, in free or salt form and optionally contacting the oral surface with a periodic oral care cleaning composition at least once monthly. The periodic oral care cleaning compositions suitable for use in the method comprise an abrasive system.
Such methods encompass contacting an oral surface with a primary oral care composition at least once daily, contacting the oral surface with a periodic oral care maintenance composition at least once monthly, wherein the periodic oral care maintenance com-position comprises a basic amino acid, in free or salt form and optionally contacting the oral surface with a periodic oral care cleaning composition at least once monthly. The periodic oral care cleaning compositions suitable for use in the method comprise an abrasive system.
Description
TITLE OF THE INVENTION
Oral Care Regimen BACKGROUND OF THE INVENTION
100021 Consumers report perceptions of refreshment. contentment, cleanliness, and general well-being similar to those experienced post-spa or beauty treatment after a professional teeth cleaning carried out by a dentist or hygienist. Thus, there is a need in the art for an at-home oral care regimen that permits consumers to re-create the "extra clean"
mouth feel and associated sense of well-being experienced after a professional teeth cleaning and that is coupled with a regimen that preserves the dental surfaces against caries.
hypersensitivity and other oral care and systemic health benefits.
BRIEF SUMMARY OF THE INVENTION
100031 The invention includes methods of cleaning an oral surface, maintaining oral health and/or increasing oral health. Sue'll methods encompass contacting an oral surface with a primary oral care composition at least once daily, contacting the oral surface with a periodic oral care maintenance composition at least once monthly. The invention optionally further comprises contacting the oral surface with a periodic oral care 'cleaning composition at least once monthly. The periodic oral care maintenance compositions suitable for use in the method comprise a basic amino acid in free or salt form. The periodic oral care cleaning compositions suitable for use in the method comprise a first abrasive having an Einlehner hardness of greater than about 5 rug loss per 100,000 revolutions and a second abrasive having an Einlehner hardness of less than about 5 mg loss per 100.000 revolutions. In the periodic oral care cleaning compositions, the ratio of the first abrasive to the second abrasive is about 1:1.6 to about 1.6:1. The periodic oral care cleaning compositions are characterized by a pellicle cleaning ratio of greater than about 100 and a radioactive dentin abrasion of less than about 200. Additionally or alternatively, the methods may include those where the second abrasive comprises silica and has an oil of absorption of greater than about 90 cm3/100g and/or an Einlehner hardness of less than about 5 mg loss per 100,000 revolutions.
The ratio of the first abrasive to the second abrasive may be about 1:1.6 to about 1.6:1. The total amount of the first and second abrasives present in the oral composition may be greater than about 25% by weight of the composition and/or the oral composition has a pellicle cleaning ratio of greater than about 100 and a radioactive dentin abrasion of less than about 200.
[0004] The present invention provides a periodic oral care maintenance composition comprising a basic amino acid, in free or salt form, for use in the therapeutic treatment of an oral surface, which treatment comprises a. contacting the oral surface with a primary oral care composition at least once daily, and b. contacting the oral surface with the periodic oral care maintenance composition at least once monthly.
[0005] The present invention further provides a combined preparation comprising a periodic oral care maintenance composition and a primary oral care composition for the manufacture of a combined preparation for simultaneous, sequential or separate administration to a subject in the therapeutic treatment of an oral surface, wherein the oral surface is:
a. contacted with the primary oral care composition at least once daily, and b. contacted the with the periodic oral care maintenance composition at least once monthly; and wherein the periodic oral care maintenance composition comprises a basic amino acid, in free or salt form.
[00061 The present invention further provides the use of a basic amino acid, in free or salt form, for the manufacture of a periodic oral care maintenance composition for the therapeutic treatment of an oral surface. which treatment comprises a. contacting the oral surface with a primary oral care composition at least once daily, and b. contacting the oral surface with the periodic oral care maintenance composition at least once monthly.
[0007] The present invention further provides the use of a periodic oral care maintenance composition and a primary oral care composition for the manufacture of a combined preparation for simultaneous, sequential or separate administration to a subject in the therapeutic treatment of an oral surface, wherein the oral surface is:
a. contacted with the primary oral care composition at least once daily, and b. contacted the with the periodic oral care maintenance composition at least once monthly; and wherein the periodic oral care maintenance composition comprises a basic amino acid, in free or salt form.
[0008] The present invention further provides a method comprising: a.
contacting an oral surface with a primary oral care composition at least once daily, and b.
contacting the oral surface with a periodic oral care maintenance composition at least once monthly, wherein the periodic oral care maintenance composition comprises a basic amino acid, in free or salt form.
[0008a] Specific aspects of the invention include:
a combination of compositions comprising a periodic oral care maintenance composition and a primary oral care composition for simultaneous, sequential or separate application to a subject in the treatment of an oral surface, wherein: a. the primary oral care composition is to be applied at least once daily to the oral surface, and b.
the periodic oral care maintenance composition is to be applied at least once monthly to the oral surface; and wherein the periodic oral care maintenance composition comprises a first abrasive, a second abrasive, and a basic amino acid, in free or salt form;
use of a periodic oral care maintenance composition and a primary oral care composition for the manufacture of a combined preparation for simultaneous, sequential or separate application to a subject in the treatment of an oral surface, wherein: a. the primary oral care composition is to be applied at least once daily to the oral surface, and b. the periodic oral care maintenance composition is to be applied at least once monthly to the oral surface;
and wherein the periodic oral care maintenance composition comprises a first abrasive, a second abrasive, and a basic amino acid, in free or salt form.
DETAILED DESCRIPTION OF THE INVENTION
[00091 The invention provides a regimen method of cleaning an oral surface to remove, for example, bacteria, food particles, biofilm, plaque, and/or other agents that may result in or contribute to various oral conditions, such as bad breath, poor oral health, gingivitis, gum inflammation, or periodontitis. The regimen method of the invention also provides the user with a smooth, polished feel and appearance to the tooth surfaces that may be perceived as comparable to the "clean feel" experienced after a professional cleaning.
Methods of maintaining oral health and/or increasing oral health are also provided.
[0010] As such the Compositions of the Invention are useful for treating oral conditions in the mouth and to clean the oral cavity and provide improved methods of promoting oral health.
[0011] Enhancing oral health also provides benefits in systemic health, as the oral tissues can be gateways for systemic infections. Good oral health is associated with systemic health, including cardiovascular health. The compositions and methods of the invention provide particular benefits because basic amino acids, especially arginine, are sources of nitrogen which supply NO synthesis pathways and thus enhance microcirculation in the oral tissues. Providing a less acidic oral environment is also helpful in reducing gastric distress and creates an environment less favourable to Heliobacter, which is associated with gastric ulcers. Arginine in particular is required for high expression of specific immune cell receptors, for example T-cell receptors, so that arginine can enhance an effective immune response. The compositions and methods of the invention are thus useful to enhance systemic health including cardiovascular health.
[0012] The primary and the periodic oral care compositions may be effective upon application to the oral cavity, e.g., with brushing, to (i) reduce or inhibit formation of dental caries, (ii) reduce, repair or inhibit pre-carious lesions of the enamel, e.g., as detected by quantitative light-induced fluorescence (QLF) or electrical caries measurement (ECM), (iii) reduce or inhibit demineralization and promote remineralisation of the teeth, (iv) reduce hypersensitivity of the teeth, (v) reduce or inhibit gingivitis, (vi) promote healing of sores or cuts in the mouth, (vii) reduce levels of acid producing bacteria, (viii) to increase relative levels of arginolytic bacteria, (ix) inhibit microbial biofilm formation in the oral cavity, (x) raise and/or maintain plaque pH at levels of at least pH 5.5 following sugar challenge.
3a (xi) reduce plaque accumulation. (xii) treat. relieve or reduce dry mouth, (xiii) clean the teeth and oral cavity (xiv) reduce erosion, (xv) whiten teeth, (xvi) immunize the teeth against cariogenic bacteria: and/or (xvii) promote systemic health. including cardiovascular health, e.g., by reducing potential for systemic infection via the oral tissues.
100131 The invention is an oral care regimen that includes contacting an oral surface with at least two oral care compositions at differing time increments. The oral surface to be treated includes any within the oral cavity. Exemplary surfaces include hard tissues (e.g., teeth) and soft surfaces (e.g., gingiva and tongue).
100141 One of the oral care compositions used in the regimen method of the invention is a primary oral care composition. The primary oral care composition may be any known or to be developed in the art and can take any form. For example, the primary oral care composition may be in the form of a rinse, paste, gel. fluid, suspension, film, patch, gum.
lozenge, confectionary, or semi-solid pates or stick. The primary oral care composition may be a conventional toothpaste, such as those sold under the COLGATE trademark (Colgate-Palmolive Company, New York. New York) or under the CREST trademark (Procter &
Gamble Corporation, Cincinnati, Ohio). Alternatively, the primary oral care composition may be any of those described in, e.g., United States Patent Nos. 4,721,614;
4,894,220;
4,986,981: 5,037,635; 5,156,835; 5,288,480; 5,344,641; 5,538,715; 5,776,435 and United States Patent Application Publication Nos. 2004/0126332. 2004/0136924, 2005/0019273, 2005/0271601. and 2005/0271602.
100151 The primary oral care composition may contain one or more agents such as hurnectants, solvents, thickeners, surfactants, abrasives, flavorants.
colorants, viscosity and/or rheology modifiers, gums, polymers, sweeteners, etc. Examples of agents that may be present in the primary oral care composition include an antibacterial agent, a plaque dispersion agent, an antiadhesion agent, an anticaries agent, a desensitizing agent, a flavorant, a colorant, a stannous ion agent, triclosan, triclosan monophosphate.
chlorliexidine, alexidine, hexctidine, sanguinarine, benzalkonium chloride, salicylanilidc. domiphen bromide.
cetylpyridinium chloride, tetradecylpyridinium chloride, N-tetradecy1-4-ethylpyriclinium chloride, octenidine, delmopinol. octapinol, nisin, zinc ion agent, copper ion agent, essential oils, furanones. bacteriocins, ethyl lauroyl arginate. extracts of magnolia, a metal ion source, arginine bicarbonate, honokiol, magonol. ursolic acid, ursic acid, morin, extract of sea buckthorn. a peroxide, an enzyme, a Carnegiet extract, a flavonoid, a llavan, halogenated diphenyl ether. creatine, and/or propolis.
[0016] In the practice of the methods of the invention, the primary oral care composition may be applied or contacted to the oral surface at least once daily. In some embodiments, the application of the primary oral care composition may be carried out two, three, four, five, six, seven times daily, or up to fifteen times daily.
100171 The oral surface may be contacted to the primary oral care composition using any means known or to be developed in the art; such means may vary depending on the form of the primary oral care composition. Exemplary means of contacting the primary oral care composition to the oral surface include application using an implement (such as a brush, toothbrush, stick, sponge. cotton swab). lavage. chewing, adjacent placement, and dissolution of confectionary.
100181 Another of the oral care compositions used in the methods of the invention is a periodic oral care maintenance composition. The oral care maintenance composition is generally applied by the consumer. The oral care maintenance composition is in a form selected from a mouthrinse, a toothpaste, a tooth gel, a tooth powder, a non-abrasive gel, a mousse. a foam, a mouth spray, a lozenge, an oral tablet, a varnish, or a sealant. The periodic oral care maintenance composition comprises an effective amount of a basic amino acid, in free or salt form, e.g., arginine. The composition may further comprise an effective amount of an antibacterial agent, e.g., triclosan and /or Zn+2 ion source, e.g., zinc citrate; an effective amount of a fluoride source, e.g., a soluble fluoride salt; and/or a polymer.
100191 In particular, the antibacterial agent may be selected from halogenated diphenyl ether (e.g. triclosan), herbal extracts and essential oils (e.g., rosemary extract, tea extract, magnolia extract, thymol, menthol, eucalyptol, geraniol, caniacrol. citral, hinokitol, catechol, methyl salicylate. epigallocatechin gallate, epigallocatechin. gal lie acid, miswak extract, sea-buckthorn extract), bisguanide antiseptics (e.g., chlorhexidine, alexidine or octenidine), quaternary ammonium compounds (e.g., cetylpyridinium chloride (CPC), benzalkonium chloride, tetradecylpyridinium chloride (TPC), N-tetradecy1-4-ethylpyridinium chloride (TDEPC)), phenolic antiseptics, hexetidine. octenidine, sanguinarine, povi done iodine, delmopinol, salifluor, metal ions (e.g., zinc salts, for example, zinc citrate, stannous salts, copper salts, iron salts), sanguinarine, propolis and oxygenating agents (e.g., hydrogen peroxide. buffered sodium peroxyborate or peroxycarbonate), phthalic acid and its salts, monoperthalic acid and its salts and esters, ascorbyl stearate, olcoyl sarcosine, alkyl sulfate, dioctyl sulfosuccinate, salicylanilide, domiphen bromide, delmopinol, octapinol and other piperidino derivatives, nicin preparations, chlorite salts; and mixtures of any of the foregoing.
100201 In some embodiments, the application of the oral care maintenance composition may be carried out daily, every other day. weekly, monthly or any other interval based on the oral care maintenance composition delivery form and desired end benefit. For example, when the oral care delivery form is a toothpaste the use is e.g., at least daily, when the oral care delivery form is a varnish the use is e.g., weekly or monthly.
100211 Another of the oral care composition used in the methods of the invention is a periodic oral care cleaning composition. The periodic oral care cleaning composition typically has a Pellicle Cleaning Ratio ("PCR") of greater than about 100, while having a Radiotracer Dentin Abrasion (-RDA") of less than about 200. In certain embodiments, the RDA is less than or equal to about 175, while still having a PCR that exceeds about 100. In some embodiments, the RDA is less than about 165. (Methods of performing PCR
and RDA
are described in e.g., United States Patent Nos. 5.939.051 and 6.290.933.
100221 The periodic oral care cleaning composition may include a first abrasive and a second abrasive; such abrasives are described in United States Publication No.
2007/0140986.
100231 In certain embodiments, the periodic oral composition comprises a first abrasive having an Einlehner hardness of greater than about 5 mg loss per 100,000 revolutions and a second abrasive having an Einlehner hardness of less than about 5 mg loss per 100.000 revolutions. The first particle having an Einlehner hardness of greater than about 5 mg loss per 100,000 revolutions has a primary a polishing function when it is contacted with an oral surface. The second particle having an Einlehner hardness of less than about 5 mg loss per 100.000 revolutions has a primary cleaning function, as it is a softer particle. In certain embodiments. the second particle has a hardness of greater than about 10 mg loss per 100.000 revolutions, and in other embodiments, greater than about 15 mg loss per 100,000 revolutions.
100241 The first abrasive of the periodic oral care cleaning composition may be of a cleaning abrasive that has a hardness of less than or equal to the oral surface to be treated, and the second abrasive is a polishing abrasive that has a hardness of greater than or equal to the oral surface to be treated.
100251 Each of the first abrasive and second abrasive of the periodic oral care cleaning composition has a particle size. In certain embodiments, the first particle size is less than the second particle size. Mean particle size can be measured. e.g.. using a Malvern Particle Size Analyzer, Model Mastersizer S. Malvern Instruments, Inc. of Southborough, Massachusetts.
U.S.A.
100261 In certain embodiments, the first abrasive has a mean particle size of less than about 11 Al11, e.g., less than about 10 pm. For example, examples of suitable abrasives have mean particle sizes ranging from about 7 p.m to about 11 pm. Some abrasives have particle sizes of less than about 5 pm. In other embodiments, the second abrasive has a mean particle size of greater than about 8 pm, e.g., greater than about 10 pm. In some embodiments, the second abrasive can have a mean particle size of about 8 pm to about 14 pm.
100271 Any orally or cosmetically acceptable abrasive fulfilling the requirements set forth above can be selected for use in the periodic oral care cleaning composition.
Suitable abrasives include without limitation, silica, silicate, silicon, alumina (including calcined aluminum oxide). aluminosilicates, such as bentonite, zeolite, kaolin, and mica, siliceous or diatomaceous earth, pumice, calcium carbonate, cuttlebone, insoluble phosphates. composite resins, such as melamine resin, phenolic resin, and urea-formaldehyde resin, polycarbonate, silicon carbide, boron carbide, microcrystalline wax, microcrystalline cellulose, including combinations of colloidal microcrystalline cellulose and carboxymethylcellulose, commercially available under the trade name AVICEL from FMC Biopolymer of Philadelphia, Pennsylvania, U.S.A, and combinations and derivatives of all of the above. By "mica" it is meant ally one of a group of hydrous aluminum silicate minerals with plate morphology and perfect basal (micaceous) cleavage. Mica can be, for example, sheet mica, scrap mica or flake mica, as exemplified by muscovite, biotite or phlogopite type micas.
Among insoluble phosphates useful as abrasives are orthophosphates, polymetaphosphates and pyrophosphates. Illustrative examples are dicalcium orthophosphate dihydrate.
dicalcium phosphate dihydrate, calcium hydrogen phosphate, calcium pyrophosphate, 0-calcium pyrophosphate, tricalcium phosphate, calcium metaphosphate, potassium metaphosphate, and sodium metaphosphate.
100281 Synthetic silicas include both silica gels and precipitated silicas which may be prepared, for example, by the neutralization of aqueous silicate solutions with a strong mineral acid. In the preparation of silica gel, a silica hydrogel is formed which is then typically washed to low salt content. The washed hydrogel may be milled to the desired size, or otherwise dried, ultimately to the point where its stntcture no longer changes as a result of shrinkage. When preparing such synthetic silicas, the objective is to obtain abrasives which provide maximal cleaning (i.e., removal of stained pellicle) with minimal damage to the tooth enamel and other oral tissue.
100291 Useful abrasive materials for preparing the periodic oral compositions include high cleaning, low structure silica abrasives, such as those marketed under the trade designation SYLODENT XWA or SYLODENT 783 by Davison Chemical Division of W. R. Grace & Co. of Baltimore. MD. SYLODENT XWA 650 is a silica hydrogel composed of particles of colloidal silica. Exemplary silica hydrogels comprise colloidal particles of silica having an average particle size of about 3 pm to about 12 pm, and e.g., between about 5 p.m to about 10 pm. with a pH range from about 4 to about 10.
e.g., about 6 to about 9 when measured as a 5% by weight slurry. The particles of the XWA
650 contain about 10 % to about 35% by weight water, have a mean particle size of about 5 p.m to about 12 m, an Einlehner hardness of from greater than or equal to about 5 to about 20 mg loss per 100.000 revolutions, an oil absorption of less than about 90 cm3/100 g. for example from between about 40 cm3/100 g to about 90 CM3/100 2. The abrasives have a Brunauer, Emmett and Teller (BET) surface area from about 100 to about 700 m2/g. XWA 650 has a brightness of about 96.8 technidyne. Such abrasives are disclosed in. e.g., United States Patent No.
6.290.933.
100301 Another high cleaning silica abrasive that can be included in the periodic composition is marketed as SYLODENT XWA 300 and is a silica hydrogel containing about 10% to about 25% water by weight, where the mean particles size is about
Oral Care Regimen BACKGROUND OF THE INVENTION
100021 Consumers report perceptions of refreshment. contentment, cleanliness, and general well-being similar to those experienced post-spa or beauty treatment after a professional teeth cleaning carried out by a dentist or hygienist. Thus, there is a need in the art for an at-home oral care regimen that permits consumers to re-create the "extra clean"
mouth feel and associated sense of well-being experienced after a professional teeth cleaning and that is coupled with a regimen that preserves the dental surfaces against caries.
hypersensitivity and other oral care and systemic health benefits.
BRIEF SUMMARY OF THE INVENTION
100031 The invention includes methods of cleaning an oral surface, maintaining oral health and/or increasing oral health. Sue'll methods encompass contacting an oral surface with a primary oral care composition at least once daily, contacting the oral surface with a periodic oral care maintenance composition at least once monthly. The invention optionally further comprises contacting the oral surface with a periodic oral care 'cleaning composition at least once monthly. The periodic oral care maintenance compositions suitable for use in the method comprise a basic amino acid in free or salt form. The periodic oral care cleaning compositions suitable for use in the method comprise a first abrasive having an Einlehner hardness of greater than about 5 rug loss per 100,000 revolutions and a second abrasive having an Einlehner hardness of less than about 5 mg loss per 100.000 revolutions. In the periodic oral care cleaning compositions, the ratio of the first abrasive to the second abrasive is about 1:1.6 to about 1.6:1. The periodic oral care cleaning compositions are characterized by a pellicle cleaning ratio of greater than about 100 and a radioactive dentin abrasion of less than about 200. Additionally or alternatively, the methods may include those where the second abrasive comprises silica and has an oil of absorption of greater than about 90 cm3/100g and/or an Einlehner hardness of less than about 5 mg loss per 100,000 revolutions.
The ratio of the first abrasive to the second abrasive may be about 1:1.6 to about 1.6:1. The total amount of the first and second abrasives present in the oral composition may be greater than about 25% by weight of the composition and/or the oral composition has a pellicle cleaning ratio of greater than about 100 and a radioactive dentin abrasion of less than about 200.
[0004] The present invention provides a periodic oral care maintenance composition comprising a basic amino acid, in free or salt form, for use in the therapeutic treatment of an oral surface, which treatment comprises a. contacting the oral surface with a primary oral care composition at least once daily, and b. contacting the oral surface with the periodic oral care maintenance composition at least once monthly.
[0005] The present invention further provides a combined preparation comprising a periodic oral care maintenance composition and a primary oral care composition for the manufacture of a combined preparation for simultaneous, sequential or separate administration to a subject in the therapeutic treatment of an oral surface, wherein the oral surface is:
a. contacted with the primary oral care composition at least once daily, and b. contacted the with the periodic oral care maintenance composition at least once monthly; and wherein the periodic oral care maintenance composition comprises a basic amino acid, in free or salt form.
[00061 The present invention further provides the use of a basic amino acid, in free or salt form, for the manufacture of a periodic oral care maintenance composition for the therapeutic treatment of an oral surface. which treatment comprises a. contacting the oral surface with a primary oral care composition at least once daily, and b. contacting the oral surface with the periodic oral care maintenance composition at least once monthly.
[0007] The present invention further provides the use of a periodic oral care maintenance composition and a primary oral care composition for the manufacture of a combined preparation for simultaneous, sequential or separate administration to a subject in the therapeutic treatment of an oral surface, wherein the oral surface is:
a. contacted with the primary oral care composition at least once daily, and b. contacted the with the periodic oral care maintenance composition at least once monthly; and wherein the periodic oral care maintenance composition comprises a basic amino acid, in free or salt form.
[0008] The present invention further provides a method comprising: a.
contacting an oral surface with a primary oral care composition at least once daily, and b.
contacting the oral surface with a periodic oral care maintenance composition at least once monthly, wherein the periodic oral care maintenance composition comprises a basic amino acid, in free or salt form.
[0008a] Specific aspects of the invention include:
a combination of compositions comprising a periodic oral care maintenance composition and a primary oral care composition for simultaneous, sequential or separate application to a subject in the treatment of an oral surface, wherein: a. the primary oral care composition is to be applied at least once daily to the oral surface, and b.
the periodic oral care maintenance composition is to be applied at least once monthly to the oral surface; and wherein the periodic oral care maintenance composition comprises a first abrasive, a second abrasive, and a basic amino acid, in free or salt form;
use of a periodic oral care maintenance composition and a primary oral care composition for the manufacture of a combined preparation for simultaneous, sequential or separate application to a subject in the treatment of an oral surface, wherein: a. the primary oral care composition is to be applied at least once daily to the oral surface, and b. the periodic oral care maintenance composition is to be applied at least once monthly to the oral surface;
and wherein the periodic oral care maintenance composition comprises a first abrasive, a second abrasive, and a basic amino acid, in free or salt form.
DETAILED DESCRIPTION OF THE INVENTION
[00091 The invention provides a regimen method of cleaning an oral surface to remove, for example, bacteria, food particles, biofilm, plaque, and/or other agents that may result in or contribute to various oral conditions, such as bad breath, poor oral health, gingivitis, gum inflammation, or periodontitis. The regimen method of the invention also provides the user with a smooth, polished feel and appearance to the tooth surfaces that may be perceived as comparable to the "clean feel" experienced after a professional cleaning.
Methods of maintaining oral health and/or increasing oral health are also provided.
[0010] As such the Compositions of the Invention are useful for treating oral conditions in the mouth and to clean the oral cavity and provide improved methods of promoting oral health.
[0011] Enhancing oral health also provides benefits in systemic health, as the oral tissues can be gateways for systemic infections. Good oral health is associated with systemic health, including cardiovascular health. The compositions and methods of the invention provide particular benefits because basic amino acids, especially arginine, are sources of nitrogen which supply NO synthesis pathways and thus enhance microcirculation in the oral tissues. Providing a less acidic oral environment is also helpful in reducing gastric distress and creates an environment less favourable to Heliobacter, which is associated with gastric ulcers. Arginine in particular is required for high expression of specific immune cell receptors, for example T-cell receptors, so that arginine can enhance an effective immune response. The compositions and methods of the invention are thus useful to enhance systemic health including cardiovascular health.
[0012] The primary and the periodic oral care compositions may be effective upon application to the oral cavity, e.g., with brushing, to (i) reduce or inhibit formation of dental caries, (ii) reduce, repair or inhibit pre-carious lesions of the enamel, e.g., as detected by quantitative light-induced fluorescence (QLF) or electrical caries measurement (ECM), (iii) reduce or inhibit demineralization and promote remineralisation of the teeth, (iv) reduce hypersensitivity of the teeth, (v) reduce or inhibit gingivitis, (vi) promote healing of sores or cuts in the mouth, (vii) reduce levels of acid producing bacteria, (viii) to increase relative levels of arginolytic bacteria, (ix) inhibit microbial biofilm formation in the oral cavity, (x) raise and/or maintain plaque pH at levels of at least pH 5.5 following sugar challenge.
3a (xi) reduce plaque accumulation. (xii) treat. relieve or reduce dry mouth, (xiii) clean the teeth and oral cavity (xiv) reduce erosion, (xv) whiten teeth, (xvi) immunize the teeth against cariogenic bacteria: and/or (xvii) promote systemic health. including cardiovascular health, e.g., by reducing potential for systemic infection via the oral tissues.
100131 The invention is an oral care regimen that includes contacting an oral surface with at least two oral care compositions at differing time increments. The oral surface to be treated includes any within the oral cavity. Exemplary surfaces include hard tissues (e.g., teeth) and soft surfaces (e.g., gingiva and tongue).
100141 One of the oral care compositions used in the regimen method of the invention is a primary oral care composition. The primary oral care composition may be any known or to be developed in the art and can take any form. For example, the primary oral care composition may be in the form of a rinse, paste, gel. fluid, suspension, film, patch, gum.
lozenge, confectionary, or semi-solid pates or stick. The primary oral care composition may be a conventional toothpaste, such as those sold under the COLGATE trademark (Colgate-Palmolive Company, New York. New York) or under the CREST trademark (Procter &
Gamble Corporation, Cincinnati, Ohio). Alternatively, the primary oral care composition may be any of those described in, e.g., United States Patent Nos. 4,721,614;
4,894,220;
4,986,981: 5,037,635; 5,156,835; 5,288,480; 5,344,641; 5,538,715; 5,776,435 and United States Patent Application Publication Nos. 2004/0126332. 2004/0136924, 2005/0019273, 2005/0271601. and 2005/0271602.
100151 The primary oral care composition may contain one or more agents such as hurnectants, solvents, thickeners, surfactants, abrasives, flavorants.
colorants, viscosity and/or rheology modifiers, gums, polymers, sweeteners, etc. Examples of agents that may be present in the primary oral care composition include an antibacterial agent, a plaque dispersion agent, an antiadhesion agent, an anticaries agent, a desensitizing agent, a flavorant, a colorant, a stannous ion agent, triclosan, triclosan monophosphate.
chlorliexidine, alexidine, hexctidine, sanguinarine, benzalkonium chloride, salicylanilidc. domiphen bromide.
cetylpyridinium chloride, tetradecylpyridinium chloride, N-tetradecy1-4-ethylpyriclinium chloride, octenidine, delmopinol. octapinol, nisin, zinc ion agent, copper ion agent, essential oils, furanones. bacteriocins, ethyl lauroyl arginate. extracts of magnolia, a metal ion source, arginine bicarbonate, honokiol, magonol. ursolic acid, ursic acid, morin, extract of sea buckthorn. a peroxide, an enzyme, a Carnegiet extract, a flavonoid, a llavan, halogenated diphenyl ether. creatine, and/or propolis.
[0016] In the practice of the methods of the invention, the primary oral care composition may be applied or contacted to the oral surface at least once daily. In some embodiments, the application of the primary oral care composition may be carried out two, three, four, five, six, seven times daily, or up to fifteen times daily.
100171 The oral surface may be contacted to the primary oral care composition using any means known or to be developed in the art; such means may vary depending on the form of the primary oral care composition. Exemplary means of contacting the primary oral care composition to the oral surface include application using an implement (such as a brush, toothbrush, stick, sponge. cotton swab). lavage. chewing, adjacent placement, and dissolution of confectionary.
100181 Another of the oral care compositions used in the methods of the invention is a periodic oral care maintenance composition. The oral care maintenance composition is generally applied by the consumer. The oral care maintenance composition is in a form selected from a mouthrinse, a toothpaste, a tooth gel, a tooth powder, a non-abrasive gel, a mousse. a foam, a mouth spray, a lozenge, an oral tablet, a varnish, or a sealant. The periodic oral care maintenance composition comprises an effective amount of a basic amino acid, in free or salt form, e.g., arginine. The composition may further comprise an effective amount of an antibacterial agent, e.g., triclosan and /or Zn+2 ion source, e.g., zinc citrate; an effective amount of a fluoride source, e.g., a soluble fluoride salt; and/or a polymer.
100191 In particular, the antibacterial agent may be selected from halogenated diphenyl ether (e.g. triclosan), herbal extracts and essential oils (e.g., rosemary extract, tea extract, magnolia extract, thymol, menthol, eucalyptol, geraniol, caniacrol. citral, hinokitol, catechol, methyl salicylate. epigallocatechin gallate, epigallocatechin. gal lie acid, miswak extract, sea-buckthorn extract), bisguanide antiseptics (e.g., chlorhexidine, alexidine or octenidine), quaternary ammonium compounds (e.g., cetylpyridinium chloride (CPC), benzalkonium chloride, tetradecylpyridinium chloride (TPC), N-tetradecy1-4-ethylpyridinium chloride (TDEPC)), phenolic antiseptics, hexetidine. octenidine, sanguinarine, povi done iodine, delmopinol, salifluor, metal ions (e.g., zinc salts, for example, zinc citrate, stannous salts, copper salts, iron salts), sanguinarine, propolis and oxygenating agents (e.g., hydrogen peroxide. buffered sodium peroxyborate or peroxycarbonate), phthalic acid and its salts, monoperthalic acid and its salts and esters, ascorbyl stearate, olcoyl sarcosine, alkyl sulfate, dioctyl sulfosuccinate, salicylanilide, domiphen bromide, delmopinol, octapinol and other piperidino derivatives, nicin preparations, chlorite salts; and mixtures of any of the foregoing.
100201 In some embodiments, the application of the oral care maintenance composition may be carried out daily, every other day. weekly, monthly or any other interval based on the oral care maintenance composition delivery form and desired end benefit. For example, when the oral care delivery form is a toothpaste the use is e.g., at least daily, when the oral care delivery form is a varnish the use is e.g., weekly or monthly.
100211 Another of the oral care composition used in the methods of the invention is a periodic oral care cleaning composition. The periodic oral care cleaning composition typically has a Pellicle Cleaning Ratio ("PCR") of greater than about 100, while having a Radiotracer Dentin Abrasion (-RDA") of less than about 200. In certain embodiments, the RDA is less than or equal to about 175, while still having a PCR that exceeds about 100. In some embodiments, the RDA is less than about 165. (Methods of performing PCR
and RDA
are described in e.g., United States Patent Nos. 5.939.051 and 6.290.933.
100221 The periodic oral care cleaning composition may include a first abrasive and a second abrasive; such abrasives are described in United States Publication No.
2007/0140986.
100231 In certain embodiments, the periodic oral composition comprises a first abrasive having an Einlehner hardness of greater than about 5 mg loss per 100,000 revolutions and a second abrasive having an Einlehner hardness of less than about 5 mg loss per 100.000 revolutions. The first particle having an Einlehner hardness of greater than about 5 mg loss per 100,000 revolutions has a primary a polishing function when it is contacted with an oral surface. The second particle having an Einlehner hardness of less than about 5 mg loss per 100.000 revolutions has a primary cleaning function, as it is a softer particle. In certain embodiments. the second particle has a hardness of greater than about 10 mg loss per 100.000 revolutions, and in other embodiments, greater than about 15 mg loss per 100,000 revolutions.
100241 The first abrasive of the periodic oral care cleaning composition may be of a cleaning abrasive that has a hardness of less than or equal to the oral surface to be treated, and the second abrasive is a polishing abrasive that has a hardness of greater than or equal to the oral surface to be treated.
100251 Each of the first abrasive and second abrasive of the periodic oral care cleaning composition has a particle size. In certain embodiments, the first particle size is less than the second particle size. Mean particle size can be measured. e.g.. using a Malvern Particle Size Analyzer, Model Mastersizer S. Malvern Instruments, Inc. of Southborough, Massachusetts.
U.S.A.
100261 In certain embodiments, the first abrasive has a mean particle size of less than about 11 Al11, e.g., less than about 10 pm. For example, examples of suitable abrasives have mean particle sizes ranging from about 7 p.m to about 11 pm. Some abrasives have particle sizes of less than about 5 pm. In other embodiments, the second abrasive has a mean particle size of greater than about 8 pm, e.g., greater than about 10 pm. In some embodiments, the second abrasive can have a mean particle size of about 8 pm to about 14 pm.
100271 Any orally or cosmetically acceptable abrasive fulfilling the requirements set forth above can be selected for use in the periodic oral care cleaning composition.
Suitable abrasives include without limitation, silica, silicate, silicon, alumina (including calcined aluminum oxide). aluminosilicates, such as bentonite, zeolite, kaolin, and mica, siliceous or diatomaceous earth, pumice, calcium carbonate, cuttlebone, insoluble phosphates. composite resins, such as melamine resin, phenolic resin, and urea-formaldehyde resin, polycarbonate, silicon carbide, boron carbide, microcrystalline wax, microcrystalline cellulose, including combinations of colloidal microcrystalline cellulose and carboxymethylcellulose, commercially available under the trade name AVICEL from FMC Biopolymer of Philadelphia, Pennsylvania, U.S.A, and combinations and derivatives of all of the above. By "mica" it is meant ally one of a group of hydrous aluminum silicate minerals with plate morphology and perfect basal (micaceous) cleavage. Mica can be, for example, sheet mica, scrap mica or flake mica, as exemplified by muscovite, biotite or phlogopite type micas.
Among insoluble phosphates useful as abrasives are orthophosphates, polymetaphosphates and pyrophosphates. Illustrative examples are dicalcium orthophosphate dihydrate.
dicalcium phosphate dihydrate, calcium hydrogen phosphate, calcium pyrophosphate, 0-calcium pyrophosphate, tricalcium phosphate, calcium metaphosphate, potassium metaphosphate, and sodium metaphosphate.
100281 Synthetic silicas include both silica gels and precipitated silicas which may be prepared, for example, by the neutralization of aqueous silicate solutions with a strong mineral acid. In the preparation of silica gel, a silica hydrogel is formed which is then typically washed to low salt content. The washed hydrogel may be milled to the desired size, or otherwise dried, ultimately to the point where its stntcture no longer changes as a result of shrinkage. When preparing such synthetic silicas, the objective is to obtain abrasives which provide maximal cleaning (i.e., removal of stained pellicle) with minimal damage to the tooth enamel and other oral tissue.
100291 Useful abrasive materials for preparing the periodic oral compositions include high cleaning, low structure silica abrasives, such as those marketed under the trade designation SYLODENT XWA or SYLODENT 783 by Davison Chemical Division of W. R. Grace & Co. of Baltimore. MD. SYLODENT XWA 650 is a silica hydrogel composed of particles of colloidal silica. Exemplary silica hydrogels comprise colloidal particles of silica having an average particle size of about 3 pm to about 12 pm, and e.g., between about 5 p.m to about 10 pm. with a pH range from about 4 to about 10.
e.g., about 6 to about 9 when measured as a 5% by weight slurry. The particles of the XWA
650 contain about 10 % to about 35% by weight water, have a mean particle size of about 5 p.m to about 12 m, an Einlehner hardness of from greater than or equal to about 5 to about 20 mg loss per 100.000 revolutions, an oil absorption of less than about 90 cm3/100 g. for example from between about 40 cm3/100 g to about 90 CM3/100 2. The abrasives have a Brunauer, Emmett and Teller (BET) surface area from about 100 to about 700 m2/g. XWA 650 has a brightness of about 96.8 technidyne. Such abrasives are disclosed in. e.g., United States Patent No.
6.290.933.
100301 Another high cleaning silica abrasive that can be included in the periodic composition is marketed as SYLODENT XWA 300 and is a silica hydrogel containing about 10% to about 25% water by weight, where the mean particles size is about
2 p.m to about 4 AM. The particles have BET surface area in the range of about 150 to about 400 m2/g of silica. The XWA 300 abrasive has an oil absorption of less than about 90 cm3/100 g silica;
and a pH. in a 5% by weight suspension in boiled (CO, free) demineralized water, equal to or greater than about 8.5. Such abrasives are disclosed in United States Patent No. 5,939.051 .
100311 Another suitable high cleaning silica that can be included in the periodic composition comprises a silica product, where the particles are about 5 % to about 35% by weight water, having a mean particle size of about 7 p.m to about 11 Ani, an Eirdeliner hardness of from about 12 to about 19, an oil absorption value of about 50 cm3/100 g to about 65 cm3/100 g. A BET surface area is about 100 to about 700 m2/g of silica. The brightness is generally reported to be greater than about 95 technidyne. Such a silica product is commercially available as ZEODENT 105 from J.M. Huber of Havre de Grace.
Maryland, U.S.A.
100321 Other abrasives that can be used include typical cleaning silica abrasives, such as precipitated silicas having a mean particle size of up to about 20 p.m.
typically at about 8 to about 14 ptin. with an oil absorption structure of greater than about 90 to about 110 cm3/100 g. such as ZEODENT 115. marketed by J. M. Huber. that has a pH at 5% of the particles of about 6.5 ¨ about 7.5 and an Einlehner hardness of about 2 to about 4 mg loss per 100.000 revolutions. The brightness of such a silica particle is greater than about 95. Such cleaning abrasives comprise the second abrasive of the oral composition in certain embodiments.
100331 The silica abrasive polishing materials useful herein, as well as the other abrasives, generally have an average particle size ranging between about 0. I
and about 30 microns, about between 5 and about 15 microns. The silica abrasives can be from precipitated silica or silica gels, such as the silica xerogels described in U.S. Pat. No.
and a pH. in a 5% by weight suspension in boiled (CO, free) demineralized water, equal to or greater than about 8.5. Such abrasives are disclosed in United States Patent No. 5,939.051 .
100311 Another suitable high cleaning silica that can be included in the periodic composition comprises a silica product, where the particles are about 5 % to about 35% by weight water, having a mean particle size of about 7 p.m to about 11 Ani, an Eirdeliner hardness of from about 12 to about 19, an oil absorption value of about 50 cm3/100 g to about 65 cm3/100 g. A BET surface area is about 100 to about 700 m2/g of silica. The brightness is generally reported to be greater than about 95 technidyne. Such a silica product is commercially available as ZEODENT 105 from J.M. Huber of Havre de Grace.
Maryland, U.S.A.
100321 Other abrasives that can be used include typical cleaning silica abrasives, such as precipitated silicas having a mean particle size of up to about 20 p.m.
typically at about 8 to about 14 ptin. with an oil absorption structure of greater than about 90 to about 110 cm3/100 g. such as ZEODENT 115. marketed by J. M. Huber. that has a pH at 5% of the particles of about 6.5 ¨ about 7.5 and an Einlehner hardness of about 2 to about 4 mg loss per 100.000 revolutions. The brightness of such a silica particle is greater than about 95. Such cleaning abrasives comprise the second abrasive of the oral composition in certain embodiments.
100331 The silica abrasive polishing materials useful herein, as well as the other abrasives, generally have an average particle size ranging between about 0. I
and about 30 microns, about between 5 and about 15 microns. The silica abrasives can be from precipitated silica or silica gels, such as the silica xerogels described in U.S. Pat. No.
3.538,230. to Pader et al. and U.S. Pat. No. 3,862,307, to Digiulio.
Particular silica xerogels are marketed under the trade name Syloid by the W.
R. Grace & Co., Davison Chemical Division. The precipitated silica materials include those marketed by the J. M. Huber Corp. under the trade name Zeodent , including the silica carrying the designation Zeodent 115 and 119. These silica abrasives are described in U.S.
Pat. No. 4.340,583.
100341 In certain embodiments, abrasive materials useful in the practice of the oral care compositions in accordance with the invention include silica gels and precipitated amorphous silica having an oil absorption value of about less than 100 cc/100 g silica and in the range of about 45 cc/l00 g to about 70 cc/100 g silica. Oil absorption values are measured using the ASTA Rub-Out Method D281. In certain embodiments, the silicas are colloidal particles having an average particle size of about 3 microns to about 12 microns, and about 5 to about microns.
100351 In particular embodiments, the particulate or abrasive materials comprise a large fraction of very small particles, e.g., having a d50 less than about 5 microns, for example small particle silica (SPS) having a d50 of about 3 to about 4 microns. for example Sorbosil AC43 (Ineos). Such small particles are particularly useful in formulations targeted at reducing hypersensitivity. The small particle component may be present in combination with a second larger particle abrasive. In certain embodiments, for example, the formulation comprises about 3 to about 8% SPS and about 25 to about 45% of a conventional abrasive, 100361 Low oil absorption silica abrasives particularly useful in the practice ofthe invention are marketed under the trade designation Sylodent XWA by Davison Chemical Division of W.R. Grace & Co., Baltimore, Md. 21203. Syloclent 650 XWA , a silica hydrogel composed of particles of colloidal silica having a water content of about 29% by weight averaging about 7 to about 10 microns in diameter, and an oil absorption of less than about 70 cc/100 g of silica is an example of a low oil absorption silica abrasive useful in the practice of the present invention. The abrasive is present in the oral care composition of the present invention at a concentration of about 10 to about 60% by weight, in other embodiment about 20 to about 45% by weight, and in another embodiment about 30 to about 50% by weight.
100371 In embodiments where the dentifrice is a clear or transparent gel, an abrasive of colloidal silica, such as those sold under the trademark SYLOID as SY LOI De 72 and SYL0fDe 74 or under the trademark SANTOCEL 100 alkali metal alumina-silicate complexes are particularly useful, since they have refractive indices close to the refractive indices of gelling agent-liquid (including water and/or humectant) systems commonly used in dentifrices.
100381 In accordance with various embodiments of the present invention, a first and a second abrasive are combined in the periodic composition to provide cleaning capability, mildness (relatively low abrasivity), and aesthetically acceptable periodic care compositions.
In various embodiments, an amount of the first abrasive to the second abrasive can be expressed by a ratio of the first abrasive to the second abrasive ranging from about 1:1.6 to about 1.6:1. For example, a ratio of the first abrasive to the second abrasive is about 1:1.
The respective amounts of the first abrasive and the second abrasive present in an oral composition may be about 13 to about 21% by weight of the oral composition.
100391 In sonic embodiments, the amount of the first abrasive is about 15%
to about 19%, and the amount of the second abrasive is about 15% to about 19% by weight of the oral composition. In certain preferred embodiments, the first abrasive is present at about 17% by weight and the second abrasive is present at about 17% by weight of the oral composition.
Thus, in accordance with various embodiments of the present invention, the total amount of abrasive in the periodic oral care cleaning composition, including the first and second abrasive is e.g., greater than about 25%, greater than about 30%, and in some embodiments.
greater than about 35% by total weight of the periodic oral care cleaning composition.
100401 In some embodiments, the periodic oral composition comprises a first abrasive having an Einlehner hardness of greater than about 5 mg loss per 100,000 revolutions and a second abrasive having an Einlehner hardness of less than about 5 mg loss per 100,000 revolutions. A ratio of the first abrasive to the second abrasive ranges from about 1:1.6 to about 1.6:1. Further, the periodic oral composition has a PCR of greater than about 100 and an RDA of less than about 200. In certain embodiments, the RDA is less than about 175. In certain embodiments, the first abrasive has an oil of absorption of less than about 90 cm3/100g, and the second abrasive has an oil of absorption of greater than about 90 cm3/100g. In some embodiments. the ratio of the first abrasive to the second abrasive is about 1:1. The total amount of the abrasives, including both the first and the second abrasives, is greater than about 30%. The first abrasive and the second abrasive are optionally present at about 17% each, respectively. In some embodiments, the first and second abrasives are respectively present in an amount of about 15% to about 19% by weight of the total periodic oral care cleaning composition. The first and second abrasives optionally comprise silica.
100411 In certain embodiments, the periodic oral composition comprises a first abrasive comprising silica, having an Einlehner hardness of greater than about 5 mg loss per 100,000 revolutions, and an oil of absorption of less than about 90 cm3/100g. The periodic oral composition further comprises a second abrasive comprising silica having an Einlehner hardness of less than about 5 mg loss per 100,000 revolutions, and an oil of absorption of greater than about 90 cm3/100g. The first abrasive is present at an amount of about 13% to about 21% by weight, likewise, the second abrasive is present in an amount of about 13% to about 21% by weight of the composition. In some embodiments, the first abrasive and the second abrasive are respectively present at about 15 % to about 19% by weight of the periodic oral composition. In certain embodiments, the first and second abrasives are respectively present in an amount of about 17% by weight of the oral composition. The PCR
is e.g., greater than about 100 and the RDA is e.g., less than about 200, and in certain embodiments, less than about 175. A total amount of the first and second abrasive present in the oral composition are e.g., greater than about 25% or e.g., greater than about 30%.
100421 In certain embodiments, the periodic oral composition comprises a first abrasive comprising silica and having an oil of absorption of less than about 90 cm3/100g and an Einlehner hardness of greater than about 5 mg loss per 100,000 revolutions.
The periodic oral composition further comprises a second abrasive comprising silica and having an oil of absorption of greater than about 90 cm3/100g and an Einlehner hardness of less than about 5 mg loss per 100,000 revolutions. A ratio of the first abrasive to the second abrasive is about 1:1.6 to about 1.6:1. Further, a total amount of the first and second abrasives present in the oral composition is greater than about 25% by weight of the composition.
100431 In certain embodiments, the periodic oral composition has a ratio of the first abrasive to the second abrasive that ranges from about 1:1.6 to about 1.6:1.
In particular embodiments, the active ingredient comprises a non-ionic antibacterial ingredient, such as a halogenated diphenyl ether like triclosan, which will be discussed in more detail below. In some embodiments, the first abrasive has an oil of absorption of less than about 90 cm3/100g and an Einlehner hardness of greater than about 5 mg loss per 100.000 revolutions, and the second abrasive has an oil of absorption of greater than about 90 cm3/100g and an Einlehner hardness of less than about 5 mg loss per 100,000 revolutions.
[00441 The periodic oral care cleaning compositions described herein (both the primary and the periodic) may comprise an orally acceptable carrier. Conventional ingredients that can be used to form the carriers for oral care compositions are well known to the skilled artisan. The carrier can be a liquid, semi-solid, or solid phase. Oral compositions can be in the form of a dentifrice (including toothpastes, toothpowders, and prophylaxis pastes).
confectionaries (including gums. beads and chews). film, paint-on gels, or any other form known to one of skill in the art where abrasives are employed. Selection of specific carrier components is dependant on the desired product form.
(00451 In certain preferred embodiments, the composition(s) are independently in the form of a dentifrice, where an exemplary carrier is substantially semi-solid or solid. The carrier can be aqueous. in which case the carrier e.g., comprises about 5% to about 95%
water. In other embodiments, the carrier is substantially non-aqueous. The carrier optionally comprises, for example, oral care active ingredients, surface active agents, such as surfactants, emulsifiers, and foam modulators, viscosity modifiers and thickeners, humectants, diluents, fillers, additional pH modifying agents, colorants, preservatives, solvents, and combinations thereof. It is understood that while general attributes of each of the above categories of materials may differ: there may be some common attributes and any given material may serve multiple purposes within two or more of such categories of materials. As recognized by one of skill in the art, the oral composition(s) optionally include other materials in addition to those components previously described, including for example.
emollients, moisturizers, mouth feel agents and the like. Examples of suitable carriers for oral compositions are disclosed in United States Patent Nos. 6,669,929, 6,379.654. and
Particular silica xerogels are marketed under the trade name Syloid by the W.
R. Grace & Co., Davison Chemical Division. The precipitated silica materials include those marketed by the J. M. Huber Corp. under the trade name Zeodent , including the silica carrying the designation Zeodent 115 and 119. These silica abrasives are described in U.S.
Pat. No. 4.340,583.
100341 In certain embodiments, abrasive materials useful in the practice of the oral care compositions in accordance with the invention include silica gels and precipitated amorphous silica having an oil absorption value of about less than 100 cc/100 g silica and in the range of about 45 cc/l00 g to about 70 cc/100 g silica. Oil absorption values are measured using the ASTA Rub-Out Method D281. In certain embodiments, the silicas are colloidal particles having an average particle size of about 3 microns to about 12 microns, and about 5 to about microns.
100351 In particular embodiments, the particulate or abrasive materials comprise a large fraction of very small particles, e.g., having a d50 less than about 5 microns, for example small particle silica (SPS) having a d50 of about 3 to about 4 microns. for example Sorbosil AC43 (Ineos). Such small particles are particularly useful in formulations targeted at reducing hypersensitivity. The small particle component may be present in combination with a second larger particle abrasive. In certain embodiments, for example, the formulation comprises about 3 to about 8% SPS and about 25 to about 45% of a conventional abrasive, 100361 Low oil absorption silica abrasives particularly useful in the practice ofthe invention are marketed under the trade designation Sylodent XWA by Davison Chemical Division of W.R. Grace & Co., Baltimore, Md. 21203. Syloclent 650 XWA , a silica hydrogel composed of particles of colloidal silica having a water content of about 29% by weight averaging about 7 to about 10 microns in diameter, and an oil absorption of less than about 70 cc/100 g of silica is an example of a low oil absorption silica abrasive useful in the practice of the present invention. The abrasive is present in the oral care composition of the present invention at a concentration of about 10 to about 60% by weight, in other embodiment about 20 to about 45% by weight, and in another embodiment about 30 to about 50% by weight.
100371 In embodiments where the dentifrice is a clear or transparent gel, an abrasive of colloidal silica, such as those sold under the trademark SYLOID as SY LOI De 72 and SYL0fDe 74 or under the trademark SANTOCEL 100 alkali metal alumina-silicate complexes are particularly useful, since they have refractive indices close to the refractive indices of gelling agent-liquid (including water and/or humectant) systems commonly used in dentifrices.
100381 In accordance with various embodiments of the present invention, a first and a second abrasive are combined in the periodic composition to provide cleaning capability, mildness (relatively low abrasivity), and aesthetically acceptable periodic care compositions.
In various embodiments, an amount of the first abrasive to the second abrasive can be expressed by a ratio of the first abrasive to the second abrasive ranging from about 1:1.6 to about 1.6:1. For example, a ratio of the first abrasive to the second abrasive is about 1:1.
The respective amounts of the first abrasive and the second abrasive present in an oral composition may be about 13 to about 21% by weight of the oral composition.
100391 In sonic embodiments, the amount of the first abrasive is about 15%
to about 19%, and the amount of the second abrasive is about 15% to about 19% by weight of the oral composition. In certain preferred embodiments, the first abrasive is present at about 17% by weight and the second abrasive is present at about 17% by weight of the oral composition.
Thus, in accordance with various embodiments of the present invention, the total amount of abrasive in the periodic oral care cleaning composition, including the first and second abrasive is e.g., greater than about 25%, greater than about 30%, and in some embodiments.
greater than about 35% by total weight of the periodic oral care cleaning composition.
100401 In some embodiments, the periodic oral composition comprises a first abrasive having an Einlehner hardness of greater than about 5 mg loss per 100,000 revolutions and a second abrasive having an Einlehner hardness of less than about 5 mg loss per 100,000 revolutions. A ratio of the first abrasive to the second abrasive ranges from about 1:1.6 to about 1.6:1. Further, the periodic oral composition has a PCR of greater than about 100 and an RDA of less than about 200. In certain embodiments, the RDA is less than about 175. In certain embodiments, the first abrasive has an oil of absorption of less than about 90 cm3/100g, and the second abrasive has an oil of absorption of greater than about 90 cm3/100g. In some embodiments. the ratio of the first abrasive to the second abrasive is about 1:1. The total amount of the abrasives, including both the first and the second abrasives, is greater than about 30%. The first abrasive and the second abrasive are optionally present at about 17% each, respectively. In some embodiments, the first and second abrasives are respectively present in an amount of about 15% to about 19% by weight of the total periodic oral care cleaning composition. The first and second abrasives optionally comprise silica.
100411 In certain embodiments, the periodic oral composition comprises a first abrasive comprising silica, having an Einlehner hardness of greater than about 5 mg loss per 100,000 revolutions, and an oil of absorption of less than about 90 cm3/100g. The periodic oral composition further comprises a second abrasive comprising silica having an Einlehner hardness of less than about 5 mg loss per 100,000 revolutions, and an oil of absorption of greater than about 90 cm3/100g. The first abrasive is present at an amount of about 13% to about 21% by weight, likewise, the second abrasive is present in an amount of about 13% to about 21% by weight of the composition. In some embodiments, the first abrasive and the second abrasive are respectively present at about 15 % to about 19% by weight of the periodic oral composition. In certain embodiments, the first and second abrasives are respectively present in an amount of about 17% by weight of the oral composition. The PCR
is e.g., greater than about 100 and the RDA is e.g., less than about 200, and in certain embodiments, less than about 175. A total amount of the first and second abrasive present in the oral composition are e.g., greater than about 25% or e.g., greater than about 30%.
100421 In certain embodiments, the periodic oral composition comprises a first abrasive comprising silica and having an oil of absorption of less than about 90 cm3/100g and an Einlehner hardness of greater than about 5 mg loss per 100,000 revolutions.
The periodic oral composition further comprises a second abrasive comprising silica and having an oil of absorption of greater than about 90 cm3/100g and an Einlehner hardness of less than about 5 mg loss per 100,000 revolutions. A ratio of the first abrasive to the second abrasive is about 1:1.6 to about 1.6:1. Further, a total amount of the first and second abrasives present in the oral composition is greater than about 25% by weight of the composition.
100431 In certain embodiments, the periodic oral composition has a ratio of the first abrasive to the second abrasive that ranges from about 1:1.6 to about 1.6:1.
In particular embodiments, the active ingredient comprises a non-ionic antibacterial ingredient, such as a halogenated diphenyl ether like triclosan, which will be discussed in more detail below. In some embodiments, the first abrasive has an oil of absorption of less than about 90 cm3/100g and an Einlehner hardness of greater than about 5 mg loss per 100.000 revolutions, and the second abrasive has an oil of absorption of greater than about 90 cm3/100g and an Einlehner hardness of less than about 5 mg loss per 100,000 revolutions.
[00441 The periodic oral care cleaning compositions described herein (both the primary and the periodic) may comprise an orally acceptable carrier. Conventional ingredients that can be used to form the carriers for oral care compositions are well known to the skilled artisan. The carrier can be a liquid, semi-solid, or solid phase. Oral compositions can be in the form of a dentifrice (including toothpastes, toothpowders, and prophylaxis pastes).
confectionaries (including gums. beads and chews). film, paint-on gels, or any other form known to one of skill in the art where abrasives are employed. Selection of specific carrier components is dependant on the desired product form.
(00451 In certain preferred embodiments, the composition(s) are independently in the form of a dentifrice, where an exemplary carrier is substantially semi-solid or solid. The carrier can be aqueous. in which case the carrier e.g., comprises about 5% to about 95%
water. In other embodiments, the carrier is substantially non-aqueous. The carrier optionally comprises, for example, oral care active ingredients, surface active agents, such as surfactants, emulsifiers, and foam modulators, viscosity modifiers and thickeners, humectants, diluents, fillers, additional pH modifying agents, colorants, preservatives, solvents, and combinations thereof. It is understood that while general attributes of each of the above categories of materials may differ: there may be some common attributes and any given material may serve multiple purposes within two or more of such categories of materials. As recognized by one of skill in the art, the oral composition(s) optionally include other materials in addition to those components previously described, including for example.
emollients, moisturizers, mouth feel agents and the like. Examples of suitable carriers for oral compositions are disclosed in United States Patent Nos. 6,669,929, 6,379.654. and
4.894.220.
100461 The oral care active ingredients include for example, anti-bacterial active agents.
anti-tartar agents. anti-caries agents, anti-inflammatory agents. anti-sensitivity agents, enzymes. nutrients, and the like. Active agents among those useful herein are also disclosed in United States Patent Nos. 6,290,933 and 6,685,921.
100471 The primary and/or periodic oral care compositions may further comprise an agent that interferes with or prevents bacterial attachment, e.g., solbrol or chitosan.
(00481 Any suitable fluoride ion source may be present in either or both of the oral composition(s), such as those recited in United States Patent No. 5,080.887.
Sources of fluoride ions, acid phosphatases, and =
pyrophosphatase enzyme inhibitors. are well known in the art as anti-caries agents.
Examples ofsuch sources are inorganic metal and/or ammonium fluoride salts and compounds, such as, for example: sodium fluoride, potassium fluoride, ammonium fluoride, amine fluoride, calcium fluoride: a copper fluoride, such as cuprous fluoride;
zinc fluoride.
barium n fluoride: sodium silicafluoride, sodium fluorosilicate. ammonium fluorosilicate, sodium fluorozirconate; and sodium monofluorophosphate. aluminum mono- and di-fluorophosphate. and fluorinated sodium calcium pyrophosphate. and combinations thereof.
The fluoride source can also be an amine fluoride, such as olaflur (N'octadecyltrimethylendiamine-N,N.N'-tris(2-ethanol)-dihydrofluoride). Sodium fluoride, amine fluoride, stannous fluoride, sodium monofluorophosphate (MFP), and mixtures thereof, are preferred. In certain embodiments the fluoride ion source includes stannous fluoride, sodium fluoride, sodium monofluorophosphate as well as mixtures thereof.
100491 In certain embodiments, the periodic and/or primary oral care compositions of the invention may also contain a source of fluoride ions or fluorine-providing ingredient in amounts sufficient to supply about 25 ppm to 25,000 ppm of fluoride ions, generally at least about 500 ppm, e.g., about 500 to about 2000 ppm, e.g., about 1000 to about 1600 ppm, e.g., about 1450 ppm. The appropriate level of fluoride will depend on the particular application.
A mouthwash, for example, would typically have about 100 to about 250 ppm fluoride. A
toothpaste for general consumer use would typically have about 1000 to about 1500 ppm, with pediatric toothpaste having somewhat less. A dentifrice or coating for professional application could have as much as 5,000 or even 25,000 ppm fluoride.
100501 The periodic and/or primary oral care compositions of the invention may comprise a calcium phosphate abrasive, e.g.. tricalcium phosphate (Ca3(PO4)2), hydroxyapatite (Ca10(PO4)40H)2), or dicalcium phosphate dihydrate (CaHPO4 = 2H20, also sometimes referred to herein as DiCal) or calcium pyrophosphate.
100511 Either or both oral composition(s) optionally comprise an anticalculus component.
such as one or more of the anti-calculus components recited in United States Patent No.
100461 The oral care active ingredients include for example, anti-bacterial active agents.
anti-tartar agents. anti-caries agents, anti-inflammatory agents. anti-sensitivity agents, enzymes. nutrients, and the like. Active agents among those useful herein are also disclosed in United States Patent Nos. 6,290,933 and 6,685,921.
100471 The primary and/or periodic oral care compositions may further comprise an agent that interferes with or prevents bacterial attachment, e.g., solbrol or chitosan.
(00481 Any suitable fluoride ion source may be present in either or both of the oral composition(s), such as those recited in United States Patent No. 5,080.887.
Sources of fluoride ions, acid phosphatases, and =
pyrophosphatase enzyme inhibitors. are well known in the art as anti-caries agents.
Examples ofsuch sources are inorganic metal and/or ammonium fluoride salts and compounds, such as, for example: sodium fluoride, potassium fluoride, ammonium fluoride, amine fluoride, calcium fluoride: a copper fluoride, such as cuprous fluoride;
zinc fluoride.
barium n fluoride: sodium silicafluoride, sodium fluorosilicate. ammonium fluorosilicate, sodium fluorozirconate; and sodium monofluorophosphate. aluminum mono- and di-fluorophosphate. and fluorinated sodium calcium pyrophosphate. and combinations thereof.
The fluoride source can also be an amine fluoride, such as olaflur (N'octadecyltrimethylendiamine-N,N.N'-tris(2-ethanol)-dihydrofluoride). Sodium fluoride, amine fluoride, stannous fluoride, sodium monofluorophosphate (MFP), and mixtures thereof, are preferred. In certain embodiments the fluoride ion source includes stannous fluoride, sodium fluoride, sodium monofluorophosphate as well as mixtures thereof.
100491 In certain embodiments, the periodic and/or primary oral care compositions of the invention may also contain a source of fluoride ions or fluorine-providing ingredient in amounts sufficient to supply about 25 ppm to 25,000 ppm of fluoride ions, generally at least about 500 ppm, e.g., about 500 to about 2000 ppm, e.g., about 1000 to about 1600 ppm, e.g., about 1450 ppm. The appropriate level of fluoride will depend on the particular application.
A mouthwash, for example, would typically have about 100 to about 250 ppm fluoride. A
toothpaste for general consumer use would typically have about 1000 to about 1500 ppm, with pediatric toothpaste having somewhat less. A dentifrice or coating for professional application could have as much as 5,000 or even 25,000 ppm fluoride.
100501 The periodic and/or primary oral care compositions of the invention may comprise a calcium phosphate abrasive, e.g.. tricalcium phosphate (Ca3(PO4)2), hydroxyapatite (Ca10(PO4)40H)2), or dicalcium phosphate dihydrate (CaHPO4 = 2H20, also sometimes referred to herein as DiCal) or calcium pyrophosphate.
100511 Either or both oral composition(s) optionally comprise an anticalculus component.
such as one or more of the anti-calculus components recited in United States Patent No.
5,292,526. In various embodiments. the anti-calculus component includes one or more polyphosphates.
The anti-calculus composition can include at least one wholly or partially neutralized alkali metal or ammonium tripolyphosphate or hexametaphosphate salt present in the oral composition at an effective anti-calculus amount. The anti-calculus component can also include at least one water soluble. linear, molecularly dehydrated polyphosphate salt effective in an anticalculus amount. The anti-calculus component can also include a mixture of potassium and sodium salts. at least one of which is present in an effective anti-calculus amount as a polyphosphate anti-calculus agent. Other useful anticalculus agents include polycarboxylate polymers and polyvinyl methyl ether/maleic anhydride (PVM/MA) copolymers, such as GANTREZ .
100521 All other substances or molecules known to be useful in oral care compositions may be included in either or both of the daily or the periodic compositions.
For example.
such additional molecules may include antibacterial agents, antiplaque agents.
desensitizing agents, anti-inflammation agents. colorants, thickeners, flavorants.
surfactants, abrasives, anti-adhesion agents, an anti-caries agent. a sensate. and/or vitamins.
100531 Other components that may be added to either or both composition include a stannous ion agent; triclosan; triclosan monophosphate; chlorhexidine;
alexidine: hexetidine;
sanguinarine; benzalkoni urn chloride; salicylanilide; domiphen bromide;
cetylpyridinium chloride (CPC); tctradecylpyridinium chloride (TPC); N-tetradecy1-4-ethylpyridinium chloride (TDEPC); octenidine; delmopinol; octapinol; nisin; zinc ion agent;
copper ion agent;
essential oils; furanones; bacteriocins, ethyl latiroyl arginate, extracts of magnolia, a metal ion source, arginine bicarbonate. honokiol, magonol, ursolic acid. ursic acid, morin, extract of sea buckthorn, a peroxide, an enzyme, a Camellia extract, a flavonoid, a flavan, halogenated diphenyl ether, creatine, chitosan and propolis.
100541 As used throughout, ranges are used as shorthand for describing each and every value that is within the range. Any value within the range can be selected as the terminus of the range. In the event of a conflict in a definition in the present disclosure and that of a cited reference, the present disclosure controls. It is understood that when formulations are described, they may be described in terms of their ingredients, as is common in the art, notwithstanding that these ingredients may react with one another in the actual formulation as it is made. stored and used. and such products are intended to be covered by the formulations described.
The anti-calculus composition can include at least one wholly or partially neutralized alkali metal or ammonium tripolyphosphate or hexametaphosphate salt present in the oral composition at an effective anti-calculus amount. The anti-calculus component can also include at least one water soluble. linear, molecularly dehydrated polyphosphate salt effective in an anticalculus amount. The anti-calculus component can also include a mixture of potassium and sodium salts. at least one of which is present in an effective anti-calculus amount as a polyphosphate anti-calculus agent. Other useful anticalculus agents include polycarboxylate polymers and polyvinyl methyl ether/maleic anhydride (PVM/MA) copolymers, such as GANTREZ .
100521 All other substances or molecules known to be useful in oral care compositions may be included in either or both of the daily or the periodic compositions.
For example.
such additional molecules may include antibacterial agents, antiplaque agents.
desensitizing agents, anti-inflammation agents. colorants, thickeners, flavorants.
surfactants, abrasives, anti-adhesion agents, an anti-caries agent. a sensate. and/or vitamins.
100531 Other components that may be added to either or both composition include a stannous ion agent; triclosan; triclosan monophosphate; chlorhexidine;
alexidine: hexetidine;
sanguinarine; benzalkoni urn chloride; salicylanilide; domiphen bromide;
cetylpyridinium chloride (CPC); tctradecylpyridinium chloride (TPC); N-tetradecy1-4-ethylpyridinium chloride (TDEPC); octenidine; delmopinol; octapinol; nisin; zinc ion agent;
copper ion agent;
essential oils; furanones; bacteriocins, ethyl latiroyl arginate, extracts of magnolia, a metal ion source, arginine bicarbonate. honokiol, magonol, ursolic acid. ursic acid, morin, extract of sea buckthorn, a peroxide, an enzyme, a Camellia extract, a flavonoid, a flavan, halogenated diphenyl ether, creatine, chitosan and propolis.
100541 As used throughout, ranges are used as shorthand for describing each and every value that is within the range. Any value within the range can be selected as the terminus of the range. In the event of a conflict in a definition in the present disclosure and that of a cited reference, the present disclosure controls. It is understood that when formulations are described, they may be described in terms of their ingredients, as is common in the art, notwithstanding that these ingredients may react with one another in the actual formulation as it is made. stored and used. and such products are intended to be covered by the formulations described.
Claims (12)
1. A combination of compositions comprising a periodic oral care maintenance composition and a primary oral care composition for simultaneous, sequential or separate application to a subject in the treatment of an oral surface, wherein:
a. the primary oral care composition is to be applied at least once daily to the oral surface, and b. the periodic oral care maintenance composition is to be applied at least once monthly to the oral surface; and wherein the periodic oral care maintenance composition comprises a first abrasive, a second abrasive, and a basic amino acid, in free or salt form.
a. the primary oral care composition is to be applied at least once daily to the oral surface, and b. the periodic oral care maintenance composition is to be applied at least once monthly to the oral surface; and wherein the periodic oral care maintenance composition comprises a first abrasive, a second abrasive, and a basic amino acid, in free or salt form.
2. The combination of compositions of claim 1 wherein the periodic oral care maintenance composition further comprises at least one of an antibacterial agent, a fluoride source, and/or a polymer.
3. The combination of compositions of claim 1 or 2, wherein the basic amino acid comprises arginine.
4. The combination of compositions of claim 3 wherein the basic amino acid is in salt form and selected from arginine phosphate, arginine bicarbonate, and arginine hydrochloride.
5. The combination of compositions of any one of claims 1 to 4, wherein the primary oral care composition comprises an antibacterial agent, a plaque dispersion agent, an antiadhesion agent, an anticaries agent, a desensitizing agent, a flavorant, a colorant, or a sensate.
6. The combination of compositions of any one of claims 1 to 5, wherein the primary oral care composition further comprises a stannous ion agent;
triclosan; triclosan monophosphate; chlorhexidine; alexidine; hexetidine; sanguinarine;
benzalkonium chloride;
salicylanilide; domiphen bromide; cetylpyridinium chloride (CPC);
tetradecylpyridinium chloride (TPC); N-tetradecyl-4-ethylpyridinium chloride (TDEPC); octenidine;
delmopinol;
octapinol; nisin; zinc ion agent; copper ion agent; essential oils; furanones;
bacteriocins, ethyl lauroyl arginate, extracts of magnolia, a metal ion source, arginine bicarbonate, honokiol, magonol, ursolic acid, ursic acid, morin, extract of sea buckthorn, a peroxide, an enzyme, a Camellia extract, a flavonoid, a flavan, halogenated diphenyl ether, creatine, chitosan or propolis.
triclosan; triclosan monophosphate; chlorhexidine; alexidine; hexetidine; sanguinarine;
benzalkonium chloride;
salicylanilide; domiphen bromide; cetylpyridinium chloride (CPC);
tetradecylpyridinium chloride (TPC); N-tetradecyl-4-ethylpyridinium chloride (TDEPC); octenidine;
delmopinol;
octapinol; nisin; zinc ion agent; copper ion agent; essential oils; furanones;
bacteriocins, ethyl lauroyl arginate, extracts of magnolia, a metal ion source, arginine bicarbonate, honokiol, magonol, ursolic acid, ursic acid, morin, extract of sea buckthorn, a peroxide, an enzyme, a Camellia extract, a flavonoid, a flavan, halogenated diphenyl ether, creatine, chitosan or propolis.
7. Use of a periodic oral care maintenance composition and a primary oral care composition for the manufacture of a combined preparation for simultaneous, sequential or separate application to a subject in the treatment of an oral surface, wherein:
a. the primary oral care composition is to be applied at least once daily to the oral surface, and b. the periodic oral care maintenance composition is to be applied at least once monthly to the oral surface; and wherein the periodic oral care maintenance composition comprises a first abrasive, a second abrasive, and a basic amino acid, in free or salt form.
a. the primary oral care composition is to be applied at least once daily to the oral surface, and b. the periodic oral care maintenance composition is to be applied at least once monthly to the oral surface; and wherein the periodic oral care maintenance composition comprises a first abrasive, a second abrasive, and a basic amino acid, in free or salt form.
8. The use of claim 7 wherein the periodic oral care maintenance composition further comprises at least one of an antibacterial agent, a fluoride source, and/or a polymer.
9. The use of claim 7 or 8, wherein the basic amino acid comprises arginine.
10. The use of claim 9 wherein the basic amino acid is in salt form and selected from arginine phosphate, arginine bicarbonate, and arginine hydrochloride.
11. The use of any one of claims 7 to 10, wherein the primary oral care composition comprises an antibacterial agent, a plaque dispersion agent, an antiadhesion agent, an anticaries agent, a desensitizing agent, a flavorant, a colorant, or a sensate.
12. The use of any one of claims 7 to 11, wherein the primary oral care composition further comprises a stannous ion agent; triclosan; triclosan monophosphate;
chlorhexidine; alexidine; hexetidine; sanguinarine; benzalkonium chloride;
salicylanilide;
domiphen bromide; cetylpyridinium chloride (CPC); tetradecylpyridinium chloride (TPC); N-tetradecyl-4-ethylpyridinium chloride (TDEPC); octenidine; delmopinol;
octapinol; nisin; zinc ion agent; copper ion agent; essential oils; furanones; bacteriocins, ethyl lauroyl arginate, extracts of magnolia, a metal ion source, arginine bicarbonate, honokiol, magonol, ursolic acid, usic acid, morin, extract of sea buckthorn, a peroxide, an enzyme, a Camellia extract, a flavonoid, a flavan, halogenated diphenyl ether, creatine, chitosan or propolis.
chlorhexidine; alexidine; hexetidine; sanguinarine; benzalkonium chloride;
salicylanilide;
domiphen bromide; cetylpyridinium chloride (CPC); tetradecylpyridinium chloride (TPC); N-tetradecyl-4-ethylpyridinium chloride (TDEPC); octenidine; delmopinol;
octapinol; nisin; zinc ion agent; copper ion agent; essential oils; furanones; bacteriocins, ethyl lauroyl arginate, extracts of magnolia, a metal ion source, arginine bicarbonate, honokiol, magonol, ursolic acid, usic acid, morin, extract of sea buckthorn, a peroxide, an enzyme, a Camellia extract, a flavonoid, a flavan, halogenated diphenyl ether, creatine, chitosan or propolis.
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2742008P | 2008-02-08 | 2008-02-08 | |
US2743108P | 2008-02-08 | 2008-02-08 | |
US2743508P | 2008-02-08 | 2008-02-08 | |
US2743208P | 2008-02-08 | 2008-02-08 | |
US61/027,435 | 2008-02-08 | ||
US12/028,782 US20080274065A1 (en) | 2006-05-09 | 2008-02-08 | Oral Care Regimen |
US12/028,782 | 2008-02-08 | ||
US61/027,420 | 2008-02-08 | ||
US61/027,432 | 2008-02-08 | ||
US61/027,431 | 2008-02-08 | ||
PCT/US2008/058650 WO2009099450A1 (en) | 2008-02-08 | 2008-03-28 | Oral care regimen |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2706481A1 CA2706481A1 (en) | 2009-08-13 |
CA2706481C true CA2706481C (en) | 2015-06-16 |
Family
ID=40122498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2706481A Expired - Fee Related CA2706481C (en) | 2008-02-08 | 2008-03-28 | Oral care regimen |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP2240153A1 (en) |
JP (1) | JP2011510981A (en) |
CN (1) | CN101938979B (en) |
AR (1) | AR065888A1 (en) |
AU (1) | AU2008349845C1 (en) |
BR (1) | BRPI0821857A2 (en) |
CA (1) | CA2706481C (en) |
CL (1) | CL2008000896A1 (en) |
CO (1) | CO6280462A2 (en) |
MX (1) | MX2010004708A (en) |
MY (1) | MY155709A (en) |
PA (1) | PA8774301A1 (en) |
PE (1) | PE20091442A1 (en) |
RU (1) | RU2012121147A (en) |
TW (1) | TWI459970B (en) |
WO (1) | WO2009099450A1 (en) |
ZA (1) | ZA201003676B (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007134003A2 (en) | 2006-05-09 | 2007-11-22 | Colgate-Palmolive Company | Oral care regimen |
US9376722B2 (en) | 2008-02-08 | 2016-06-28 | Colgate-Palmolive Company | Oral care methods and systems |
EP2249786B1 (en) | 2008-02-08 | 2017-07-19 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
EP2637634B1 (en) * | 2010-11-12 | 2017-05-17 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
CN107432832A (en) * | 2010-11-12 | 2017-12-05 | 高露洁-棕榄公司 | Oral care product and its use and preparation method |
EP2675425B1 (en) | 2011-02-18 | 2019-01-23 | GABA International Holding GmbH | Dentifrice composition |
JP6038567B2 (en) * | 2012-09-21 | 2016-12-07 | 花王株式会社 | Oral composition |
BR112015012921B1 (en) * | 2012-12-05 | 2018-12-04 | Colgate-Palmolive Company | toothpaste, mouthwash and use of zinc and arginine phosphate in their preparation |
RU2673473C2 (en) * | 2013-12-27 | 2018-11-27 | Колгейт-Палмолив Компани | Prebiotic oral care compositions containing carboxylic acids |
WO2015157261A1 (en) * | 2014-04-10 | 2015-10-15 | Basf Se | Oral care compositions |
CA2952776C (en) * | 2014-08-18 | 2021-06-08 | Colgate-Palmolive Company | Mouthwash composition comprising a peroxide source and an n-acyl-l-arginine alkyl ester salt |
JP2016006102A (en) * | 2015-08-14 | 2016-01-14 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | Oral care product and method of use and manufacture thereof |
EP3347005B1 (en) * | 2015-09-11 | 2021-07-07 | Wm. Wrigley Jr. Company | Synergistic antibacterial effects of magnolia bark extract and l-arginine, n-alpha-lauroyl ethyl ester on plaque biofilm |
US10617620B2 (en) * | 2016-06-24 | 2020-04-14 | Colgate-Palmolive Company | Oral care compositions and methods of use |
EP3522856B1 (en) * | 2016-11-08 | 2022-03-23 | Colgate-Palmolive Company | Oral care compositions |
WO2018089394A1 (en) * | 2016-11-08 | 2018-05-17 | Colgate-Palmolive Company | Oral care compositions |
RU2750199C2 (en) * | 2017-06-14 | 2021-06-23 | Колгейт-Палмолив Компани | Compositions containing zink phosphate |
US11382846B2 (en) | 2017-12-18 | 2022-07-12 | Colgate-Palmolive Company | Desensitizing oral care compositions and methods for the same |
US11642199B2 (en) * | 2018-09-24 | 2023-05-09 | 3M Innovative Properties Company | Dental appliance with cosmetic therapeutic aqueous solution |
MX2021011553A (en) * | 2019-03-29 | 2021-10-26 | Colgate Palmolive Co | Oral care product. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5370865A (en) * | 1992-05-15 | 1994-12-06 | Kao Corporation | Composition for use in oral cavity |
JP2627709B2 (en) * | 1992-05-15 | 1997-07-09 | 花王株式会社 | Oral composition |
JP3803695B2 (en) * | 1994-11-28 | 2006-08-02 | サンスター株式会社 | Antibacterial preparation |
US5762911A (en) * | 1996-03-05 | 1998-06-09 | The Research Foundation Of State University Of New York | Anti-caries oral compositions |
US6436370B1 (en) * | 1999-06-23 | 2002-08-20 | The Research Foundation Of State University Of New York | Dental anti-hypersensitivity composition and method |
WO2007134003A2 (en) * | 2006-05-09 | 2007-11-22 | Colgate-Palmolive Company | Oral care regimen |
-
2008
- 2008-03-28 PA PA20088774301A patent/PA8774301A1/en unknown
- 2008-03-28 CA CA2706481A patent/CA2706481C/en not_active Expired - Fee Related
- 2008-03-28 PE PE2008000569A patent/PE20091442A1/en not_active Application Discontinuation
- 2008-03-28 MY MYPI2010001791A patent/MY155709A/en unknown
- 2008-03-28 BR BRPI0821857-9A2A patent/BRPI0821857A2/en not_active IP Right Cessation
- 2008-03-28 CN CN200880126684.2A patent/CN101938979B/en not_active Expired - Fee Related
- 2008-03-28 CL CL2008000896A patent/CL2008000896A1/en unknown
- 2008-03-28 WO PCT/US2008/058650 patent/WO2009099450A1/en active Application Filing
- 2008-03-28 AU AU2008349845A patent/AU2008349845C1/en not_active Ceased
- 2008-03-28 JP JP2010544953A patent/JP2011510981A/en active Pending
- 2008-03-28 EP EP08769086A patent/EP2240153A1/en not_active Withdrawn
- 2008-03-28 MX MX2010004708A patent/MX2010004708A/en not_active Application Discontinuation
- 2008-03-31 AR ARP080101325A patent/AR065888A1/en unknown
- 2008-04-07 TW TW097112585A patent/TWI459970B/en active
-
2010
- 2010-05-21 CO CO10061135A patent/CO6280462A2/en not_active Application Discontinuation
- 2010-05-24 ZA ZA2010/03676A patent/ZA201003676B/en unknown
-
2012
- 2012-05-22 RU RU2012121147/15A patent/RU2012121147A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2011510981A (en) | 2011-04-07 |
MX2010004708A (en) | 2010-06-07 |
AU2008349845C1 (en) | 2012-09-20 |
AR065888A1 (en) | 2009-07-08 |
CN101938979B (en) | 2014-11-26 |
TWI459970B (en) | 2014-11-11 |
PE20091442A1 (en) | 2009-09-24 |
MY155709A (en) | 2015-11-13 |
CA2706481A1 (en) | 2009-08-13 |
RU2012121147A (en) | 2013-11-27 |
CN101938979A (en) | 2011-01-05 |
TW200934519A (en) | 2009-08-16 |
BRPI0821857A2 (en) | 2014-09-30 |
AU2008349845A1 (en) | 2009-08-13 |
PA8774301A1 (en) | 2009-09-17 |
CO6280462A2 (en) | 2011-05-20 |
EP2240153A1 (en) | 2010-10-20 |
ZA201003676B (en) | 2014-11-26 |
CL2008000896A1 (en) | 2009-08-14 |
WO2009099450A1 (en) | 2009-08-13 |
AU2008349845B2 (en) | 2012-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2706481C (en) | Oral care regimen | |
US8501161B2 (en) | Oral care regimen | |
US9682027B2 (en) | Oral care product and methods of use and manufacture thereof | |
EP2934451B1 (en) | Two component compositions containing zinc amino acid halide complexes and cysteine | |
EP2249787B1 (en) | Oral care product and methods of use and manufacture thereof | |
AU2010363052A1 (en) | Oral care composition comprising arginine and calcium carbonate | |
WO2009100263A2 (en) | Oral care product and methods of use and manufacture thereof | |
US20080274065A1 (en) | Oral Care Regimen | |
US20150342851A1 (en) | Two component compositions containing zinc amino acid halide complexes and cysteine | |
US20090202452A1 (en) | Oral care regimen | |
US11260009B2 (en) | Oral care product and methods of use and manufacture thereof | |
AU2012204031B2 (en) | Oral care product and methods of use and manufacture thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20170328 |